NO20071299L - Vedvarende frigivelse farmasoytisk sammensetning av tolterodine - Google Patents

Vedvarende frigivelse farmasoytisk sammensetning av tolterodine

Info

Publication number
NO20071299L
NO20071299L NO20071299A NO20071299A NO20071299L NO 20071299 L NO20071299 L NO 20071299L NO 20071299 A NO20071299 A NO 20071299A NO 20071299 A NO20071299 A NO 20071299A NO 20071299 L NO20071299 L NO 20071299L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
tolterodine
sustained release
release pharmaceutical
composition
Prior art date
Application number
NO20071299A
Other languages
English (en)
Inventor
Tadeja Rajer
Robert Pisek
Andrejka Kramer
Original Assignee
Krka Dd Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34926332&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071299(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Krka Dd Novo Mesto filed Critical Krka Dd Novo Mesto
Publication of NO20071299L publication Critical patent/NO20071299L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse angår en vedvarende frigivelse farmasøytisk sammensetning som innbefatter tolterodin, foretrukket tolterodintartrat, anvendelse av nevnte sammensetning for fremstilling av et medikament og en fremgangsmåte for fremstilling av en vedvarende frigivelse farmasøytisk sammensetning.
NO20071299A 2004-08-27 2007-03-09 Vedvarende frigivelse farmasoytisk sammensetning av tolterodine NO20071299L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04020431A EP1629834A1 (en) 2004-08-27 2004-08-27 Sustained release pharmaceutical composition of tolterodine
PCT/EP2005/009102 WO2006021425A1 (en) 2004-08-27 2005-08-23 Sustained release pharmaceutical composition of tolterodine

Publications (1)

Publication Number Publication Date
NO20071299L true NO20071299L (no) 2007-05-29

Family

ID=34926332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071299A NO20071299L (no) 2004-08-27 2007-03-09 Vedvarende frigivelse farmasoytisk sammensetning av tolterodine

Country Status (7)

Country Link
EP (3) EP1629834A1 (no)
AT (1) ATE505187T1 (no)
DE (1) DE602005027469D1 (no)
EA (1) EA200700484A1 (no)
NO (1) NO20071299L (no)
UA (1) UA87515C2 (no)
WO (1) WO2006021425A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008011952A (es) * 2006-03-21 2008-10-01 Teva Pharma Formulacion de liberacion controlad de tolterodina.
EP1839649A1 (en) 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
KR100851033B1 (ko) * 2007-02-12 2008-08-12 명문제약주식회사 엘-주석산 톨터로딘 함유 서방성 제제의 제조방법
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
WO2012154774A1 (en) 2011-05-10 2012-11-15 Theravida, Inc. Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
CN103211784B (zh) * 2012-01-18 2017-07-11 北京天衡药物研究院有限公司 酒石酸托特罗定膜控缓释微丸胶囊
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
WO2017127073A1 (en) 2016-01-20 2017-07-27 Theravida, Inc. Methods and compositions for treating hyperhidrosis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE2061C1 (no) † 1890-01-25
SE8800207D0 (sv) 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
US6274171B1 (en) † 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
CA2259012C (en) 1996-07-19 2008-05-13 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
KR20000057548A (ko) 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
CZ302630B6 (cs) † 1998-08-27 2011-08-10 Pharmacia & Upjohn Ab Farmaceutický prostredek obsahující tolterodin nebo tolterodinu príbuznou slouceninu
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
DE19901692C2 (de) † 1999-01-18 2002-06-20 Gruenenthal Gmbh Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
DE60021749T2 (de) † 1999-11-11 2006-04-20 Pfizer Health Ab Pharmazeutische formulierung enthaltend tolterodin sowie ihre verwendung
SE9904850D0 (sv) 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
IN191835B (no) 2001-08-03 2004-01-10 Ranbaxy Lab Ltd
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
AU2002360717A1 (en) * 2001-12-20 2003-07-09 Pharmacia Corporation Controlled release dosage form having improved drug release properties
KR100540035B1 (ko) † 2002-02-01 2005-12-29 주식회사 태평양 다단계 경구 약물 방출 제어 시스템
US7005449B2 (en) 2002-04-23 2006-02-28 Pharmacia & Upjohn Company Tolterodine salts
CN1150160C (zh) 2002-04-29 2004-05-19 上海医药工业研究院 L－酒石酸托特罗定的合成方法
WO2004105735A1 (en) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Controlled release pharmaceutical compositions of tolterodine and processes for their preparation

Also Published As

Publication number Publication date
EP1964553A1 (en) 2008-09-03
UA87515C2 (ru) 2009-07-27
ATE505187T1 (de) 2011-04-15
EP1781275A1 (en) 2007-05-09
EP1781275B1 (en) 2011-04-13
DE602005027469D1 (de) 2011-05-26
EP1629834A1 (en) 2006-03-01
EA200700484A1 (ru) 2007-10-26
WO2006021425A1 (en) 2006-03-02
EP1781275B2 (en) 2014-04-16

Similar Documents

Publication Publication Date Title
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
NO20074086L (no) Fremgangsmate for fremstilling av lansoprazol
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
LTPA2014019I1 (lt) Fenetanolamino dariniai, skirti kvėpavimo ligoms gydyti
MX374396B (es) Rocio de fentanilo sublingual.
NO20076687L (no) Oral doseringsform
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
CY1113024T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου για τη θεραπεια της εξαρτησης ουσιων
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
SMT201200014B (it) Nalmefene cloridrato diidrato.
ATE453642T1 (de) Substituierte phenylaminopyrimidine
NO20080967L (no) Benzimidazoler nyttige som inhibitorer av proteinkinaser
UY29876A1 (es) Derivados de acidos dicarboxilicos y su uso
ATE541573T1 (de) Pharmazeutische zusammensetzung enthaltend lapatinib
EA200700484A1 (ru) Фармацевтическая композиция толтеродина с пролонгированным высвобождением
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
TW200612922A (en) Inhibitors of hsp90
CY1108916T1 (el) Υποκαθιστουμενες πυρρολες, οι ενωσεις που τις περιεχουν, διαδικασια παρασκευης και χρηση τους
CR7271A (es) Formulaciones farmaceuticas novedosas a base de melatonina y compuestos similares para su uso en transtornos del sueno
ATE527997T1 (de) Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
DE602005002776D1 (de) Verfahren zur Herstellung von 1,3-Dihydro-2H-3-Benzazepin-2-on und Anwendung zur Herstellung von Ivabradine und ihren pharmazeutischen annehmbaren Salzen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application